Actress Angelina Jolie underwent a preventative double mastectomy after doctors estimated she had an 87% risk of breast cancer and 50% chance of ovarian cancer, she revealed on Tuesday in a New York Times op-ed.
“Cancer is still a word that strikes fear into people’s hearts, producing a deep sense of powerlessness,” she wrote in the article, which she hopes will help other women benefit from her experience. She added that she feels empowered, but not diminished.
The Oscar-winning actress, who is 37, carries a faulty gene, BRCA1, that sharply increases her risk of developing breast and ovarian cancer. Her process began on Feb. 2 and ended on April 27 after three months of medical procedures.
A mastectomy is an operation that removes all or part of the breast. Other ways to prevent breast cancer include mammography screening and breast self examinations. Prevention offers the most cost-effective long-term strategy for the control of cancer, according to the World Health Organization (WHO).
“The decision to have a double mastectomy is obviously a complicated one, and it’s one that patients should make in consultation with their doctors and with their family, taking into account the long-term risk of developing breast cancer and the quality of life issues that attend to such decisions,” Dr. Stephen Grobmyer of the Cleveland Clinic Breast Center said Tuesday on Jansing & Co.
BRCA counseling about genetic testing for women must be covered by health insurance under the Affordable Care Act, but only when the service is delivered by a network provider. Many women won’t have health insurance that will pay for the expense of the genetic test.
“Where a woman lives and how much money she has should never determine whether she lives,” Ambassador Nancy Brinker, founder of the Susan G. Komen for the Cure, said on the show.
Jolie’s mother, actress and producer Marcheline Bertrand, died from cancer in 2007 at the age of 56.








